Aereo Hits Boston O...
Health Care: Drugs
Generex Biotechnology Corporation (GNBT: OTC)
$0.03 0.00 | 1.11%
05/21/13 - 03:38 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.04 |
| 52 Week High | 0.12 |
| 52 Week Low | 0.02 |
| Avg. Daily Vol. (Mil) | 0.00 |
| Beta (3 year) | 1.99 |
| Share Related Items | |
| Mkt Cap (Mil) | 19.50 |
| Shares Out (Mil) | 490.00 |
| Float (Mil) | 410.85 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.10 |
| Current Ratio | 0.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.42K |
| Price/Book | 0.00 |
| Price/Cash Flow | -3.90 |
| Per Share Data | |
| Earnings | -0.02 |
| Sales | 0.00 |
| Book Value | 0.00 |
| Cash Flow | -0.01 |
| Business Summary | |
|---|---|
| Generex Biotechnology Corp. is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. | |
| General Information | |
| 33 Harbour Square
Suite 604 Toronto, ON M5V 3B1 |
|
| www.generex.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 11 | |
| CEO: Mr. Mark A. Fletcher | |
| Short Interest | |
| Current Month (Mil) | 7.21 |
| Previous Month (Mil) | 5.14 |
| Short Interest Ratio (Days) | 1.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -119.00 |
| Return on Investments | 51.80 |
| Profitability | |
| Gross Margin | 69.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with GNBT
- Portfolio NameUser Type
- Userroy
- Userphospho
- Userjetpilot Portfolio 1
- UserEmerging biotech
- Userpdehenau Portfolio 1
- Usernvoelz Portfolio 1
- UserCER777 Portfolio 1
- UserDoc's Picks
- Usermy pikz
- Userterri cal
Latest GNBT Headlines from TheStreet
- Biotech Stock Mailbag: Generex 10.01.10 | 07:10 am
- Generex Oncology Announces Consultancy Of Dr. George E. Peoples, MD 09.02.10 | 09:09 am
- Generex Biotechnology Initiates Social Media Campaign For Its Corporate And E-Commerce Websites 09.01.10 | 09:09 am
- Generex Informs Stockholders Of Minimum Exchange Ratio For Reverse Stock Split Proposal To Be Considered At The Special Meeting Of Stockholders On September 17, 2010 08.27.10 | 04:08 pm
- Generex Oncology Names Dr. Craig Eagle To Its Scientific Advisory Board To Assist With Its Proprietary Cancer Vaccines Program 08.05.10 | 09:08 am
- Generex Biotechnology Creates Scientific Advisory Board To Further The Progression Of Its Drug Development Programs 08.02.10 | 09:08 am
- Generex Announces AGM Results 07.30.10 | 04:07 pm
- Generex Provides Positive Update On Generex Oral-Lyn(TM) Pivotal Phase III Trial 07.28.10 | 09:07 am
- Generex's Glucose RapidSpray(TM) Now Available At Boots UK Retail Chain Stores 07.15.10 | 09:07 am
- Generex Announces Receipt Of Favorable NASDAQ Listing Determination 07.15.10 | 07:07 am
Press Releases for GNBT
- Generex Comments On Results Of Stockholders` Meeting - PR Newswire 04.03.13 | 09:04 am
- Generex Touts Pipeline Potential Of Antigen Express Subsidiary - PR Newswire 02.07.13 | 09:02 am
- Generex Points To Potential Of Antigen Express Technology Platform Beyond Its AE37 Breast Cancer Vaccine - PR Newswire 01.31.13 | 09:01 am
- Generex Provides An Overview Of Its Cancer Immunotherapy Product, AE37, And Potential In Early Breast Cancer Given Current And Potential Future Therapies - PR Newswire 01.30.13 | 09:01 am
- Generex Announces Details Of Investor Conference Call - PR Newswire 01.29.13 | 09:01 am
- Generex Oral-lynâ¿¢ Phase III Dossier Submitted To Indian Government For Marketing Approval - PR Newswire 01.23.13 | 09:01 am
- Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview - PR Newswire 01.17.13 | 09:01 am
- Generex Announces Investor Conference Call - PR Newswire 01.11.13 | 09:01 am
- Generex Announces $750,000 Capital Investment - PR Newswire 12.11.12 | 05:12 pm
- Generex Provides Update On Company Initiatives Including The AE37 Breast Cancer Vaccine Program - PR Newswire 11.13.12 | 09:11 am
Partner Headlines for GNBT
- Weekly CFO Sells Highlight: TDG, GNBT, ADGE, HFC, AMSWA - GuruFocus 07.02.12 | 05:07 pm
- Generex Announces Sales Agreement with Elias Shaker & Company (GNBT) - Benzinga 09.20.10 | 09:09 am
- Good News for Generex: Positive Data on Oral Insulin Coming in September - Seeking Alpha 08.16.10 | 08:08 am
- Generex: Reverse Split Not Approved - Seeking Alpha 08.01.10 | 08:08 am
- Four Small Caps for Binary Event Investors - Seeking Alpha 05.24.10 | 03:05 am
- Why Biodel is Breathing Easy, Part 2 - Seeking Alpha 05.03.10 | 05:05 pm
- Why Biodel is Breathing Easy, Part 1 - Seeking Alpha 05.03.10 | 05:05 pm
- Generex's Insulin Product: When a Company Misrepresents 'Compassionate Use' - SeekingAlpha.com 04.29.10 | 11:04 am
- Generex's Antigen Express: Creating the Next Generation of Cancer Immunotherapy - SeekingAlpha.com 04.14.10 | 04:04 am
- Tengion's IPO Comes In Well Below Initial Range: Biotech's Latest Deals, Financings - SeekingAlpha.com 04.11.10 | 08:04 am
